OXiris for Abdominal SEptic Shock (OASES Study)

NANot yet recruitingINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

May 31, 2027

Conditions
Septic ShockAbdominal SepsisMulti Organ FailureBlood PurificationAKI - Acute Kidney Injury
Interventions
DEVICE

CRRT filter

The subjects will be accepted CRRT using a filter for 72 hours. The subjects will be continued to CRRT or not after 72 hours (the first session of treatment) according to clinical situation by clinician decision. CRRT prescription: 1 Blood purification access: Central vein indwelling double lumen catheter (diameter 11F-13.5F) can be placed in femoral vein, internal jugular vein and subclavian vein; 2.Anti-coagulation prescription: Anticoagulant is used according clinical situation by clinician decision (such as heparin, sodium citrate, and so on); 3. Modality of CRRT: CVVH: blood flow 150-200ml/min; replacement fluid flow 30-35ml/kg/h (100% post-dilution).

Trial Locations (1)

200127

Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT06504316 - OXiris for Abdominal SEptic Shock (OASES Study) | Biotech Hunter | Biotech Hunter